|
|
Volumn 3, Issue 4, 2012, Pages 361-362
|
|
Attacking tumor cells with a dual ligand for innate immune receptors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
FLAGELLIN;
INTERLEUKIN 18;
INTERLEUKIN 1BETA;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR;
TOLL LIKE RECEPTOR 5;
INFLAMMASOME;
LIGAND;
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN;
TOLL LIKE RECEPTOR;
TUMOR ANTIGEN;
ANTIGEN PRESENTATION;
ANTINEOPLASTIC ACTIVITY;
CELL DEATH;
CYTOKINE PRODUCTION;
CYTOKINE RESPONSE;
HUMAN;
INNATE IMMUNITY;
NONHUMAN;
NOTE;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN PROCESSING;
PROTEIN PROTEIN INTERACTION;
SIGNAL TRANSDUCTION;
TARGET CELL;
TUMOR CELL;
TUMOR VASCULARIZATION;
ANIMAL;
EDITORIAL;
IMMUNOLOGY;
METABOLISM;
NEOPLASM;
PATHOLOGY;
T LYMPHOCYTE;
ANIMALS;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
HUMANS;
IMMUNITY, INNATE;
INFLAMMASOMES;
LIGANDS;
NEOPLASMS;
NOD SIGNALING ADAPTOR PROTEINS;
T-LYMPHOCYTES;
TOLL-LIKE RECEPTORS;
|
|
EID: 84867182284
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.484 Document Type: Note |
|
Times cited : (4)
|
|
References (9)
|
